Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Diabetics More Prone to Need Carpal Tunnel Surgery

By HospiMedica staff writers
Posted on 16 Apr 2008
A new study has found that patients with type 2 diabetes are more than four times more likely to undergo carpal tunnel decompression (CTD) surgery than are people without diabetes.

Researchers at the University of Western Australia (Fremantle) studied data on 1248 type 2 diabetic participants (mean age 64.1 years, 49.1% male) who were registered in the observational Fremantle Diabetes Study, all of whom had no prior history of CTD. More...
The researchers found that 67 participants (5.8%) had a first CTD during 12,109 patient years of follow-up. This amounted to an incidence of 5.5 per 1000 patient-years, a rate that was at least 4.2 times that in the general population. The researchers found that in Cox proportional hazards analysis, significant independent determinants of first-ever CTD were higher body mass index (BMI), taking lipid-lowering medication, and being in a stable relationship. The study was published in the March 2008 issue of Diabetes Care.

"Diabetic patients have decompression surgery for carpal tunnel syndrome much more frequently than people without diabetes,” said lead author Timothy Davis, Ph.D. "Our data suggest that the decision to go ahead with the procedure is influenced by obesity and overweight, which is likely to increase the severity of the symptoms associated with carpal tunnel syndrome.”

Carpal tunnel syndrome (CTS) is the most common and widely known of the entrapment neuropathies, and occurs when the median nerve is pressed or squeezed in the carpal tunnel - a narrow, rigid passageway of ligament and bones at the base of the hand that houses the median nerve and tendons. CTD is generally recommended if CTS symptoms last for 6 months, and involves severing the band of tissue around the wrist to reduce pressure on the median nerve. Surgical options include open release and endoscopic surgery.


Related Links:
University of Western Australia

Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Head Rest
Medifa 61114_3
Digital Color Doppler Ultrasound System
MS22Plus
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The researchers grew pancreatic tissue (above) so it incorporated a mesh-like electronic network (red). Cells within the tissue produce insulin (green). (Photo courtesy of Penn Medicine)

‘Cyborg’ Transplants Could Replace Pancreatic Tissue Damaged by Diabetes

Type 1 diabetes destroys insulin-producing islet cells, forcing patients to rely on lifelong insulin therapy or scarce organ transplants. Although lab-grown pancreatic tissue offers a promising alternative,... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.